nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.154	0.343	CbGbCtD
Dorzolamide—CYP2C9—Progesterone—uterine cancer	0.102	0.227	CbGbCtD
Dorzolamide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0894	0.199	CbGbCtD
Dorzolamide—CYP3A4—Progesterone—uterine cancer	0.0592	0.132	CbGbCtD
Dorzolamide—CYP3A4—Etoposide—uterine cancer	0.0265	0.059	CbGbCtD
Dorzolamide—CYP3A4—Doxorubicin—uterine cancer	0.0181	0.0403	CbGbCtD
Dorzolamide—CA6—exocrine gland—uterine cancer	0.013	0.164	CbGeAlD
Dorzolamide—CA5A—female reproductive system—uterine cancer	0.0065	0.0825	CbGeAlD
Dorzolamide—CA7—renal system—uterine cancer	0.0054	0.0685	CbGeAlD
Dorzolamide—CA2—exocrine gland—uterine cancer	0.00446	0.0566	CbGeAlD
Dorzolamide—CA9—female reproductive system—uterine cancer	0.00379	0.0482	CbGeAlD
Dorzolamide—CA12—renal system—uterine cancer	0.0035	0.0445	CbGeAlD
Dorzolamide—CA5B—mammalian vulva—uterine cancer	0.00294	0.0373	CbGeAlD
Dorzolamide—CA12—female reproductive system—uterine cancer	0.00281	0.0356	CbGeAlD
Dorzolamide—CA1—renal system—uterine cancer	0.00278	0.0353	CbGeAlD
Dorzolamide—CA5B—female reproductive system—uterine cancer	0.00252	0.032	CbGeAlD
Dorzolamide—CA5B—vagina—uterine cancer	0.00228	0.0289	CbGeAlD
Dorzolamide—CA1—female reproductive system—uterine cancer	0.00222	0.0282	CbGeAlD
Dorzolamide—CA4—renal system—uterine cancer	0.00217	0.0276	CbGeAlD
Dorzolamide—CA2—epithelium—uterine cancer	0.00194	0.0246	CbGeAlD
Dorzolamide—CA2—smooth muscle tissue—uterine cancer	0.00187	0.0237	CbGeAlD
Dorzolamide—CA2—decidua—uterine cancer	0.00183	0.0233	CbGeAlD
Dorzolamide—CA2—renal system—uterine cancer	0.0018	0.0228	CbGeAlD
Dorzolamide—CA4—female reproductive system—uterine cancer	0.00174	0.0221	CbGeAlD
Dorzolamide—CA2—mammalian vulva—uterine cancer	0.00168	0.0214	CbGeAlD
Dorzolamide—CA4—female gonad—uterine cancer	0.00158	0.0201	CbGeAlD
Dorzolamide—CA5B—lymph node—uterine cancer	0.00147	0.0187	CbGeAlD
Dorzolamide—CA2—female reproductive system—uterine cancer	0.00144	0.0183	CbGeAlD
Dorzolamide—CA2—female gonad—uterine cancer	0.00131	0.0167	CbGeAlD
Dorzolamide—CA2—vagina—uterine cancer	0.0013	0.0165	CbGeAlD
Dorzolamide—CA1—lymph node—uterine cancer	0.0013	0.0165	CbGeAlD
Dorzolamide—CYP2C9—female reproductive system—uterine cancer	0.00122	0.0155	CbGeAlD
Dorzolamide—CYP3A4—renal system—uterine cancer	0.00116	0.0147	CbGeAlD
Dorzolamide—CA4—lymph node—uterine cancer	0.00102	0.0129	CbGeAlD
Dorzolamide—Atrioventricular block—Doxorubicin—uterine cancer	0.00101	0.00213	CcSEcCtD
Dorzolamide—Blood urea increased—Epirubicin—uterine cancer	0.000997	0.00211	CcSEcCtD
Dorzolamide—Agranulocytosis—Etoposide—uterine cancer	0.000983	0.00208	CcSEcCtD
Dorzolamide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000981	0.00208	CcSEcCtD
Dorzolamide—Dry eye—Epirubicin—uterine cancer	0.000975	0.00206	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000973	0.00206	CcSEcCtD
Dorzolamide—Hypersensitivity—Progesterone—uterine cancer	0.000968	0.00205	CcSEcCtD
Dorzolamide—Dermatitis contact—Doxorubicin—uterine cancer	0.000965	0.00204	CcSEcCtD
Dorzolamide—Abnormal dreams—Doxorubicin—uterine cancer	0.000965	0.00204	CcSEcCtD
Dorzolamide—Discomfort—Dactinomycin—uterine cancer	0.000957	0.00203	CcSEcCtD
Dorzolamide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000946	0.002	CcSEcCtD
Dorzolamide—Asthenia—Progesterone—uterine cancer	0.000942	0.002	CcSEcCtD
Dorzolamide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000941	0.00199	CcSEcCtD
Dorzolamide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000941	0.00199	CcSEcCtD
Dorzolamide—Pulmonary oedema—Epirubicin—uterine cancer	0.00094	0.00199	CcSEcCtD
Dorzolamide—CYP3A4—female reproductive system—uterine cancer	0.00093	0.0118	CbGeAlD
Dorzolamide—Pruritus—Progesterone—uterine cancer	0.000929	0.00197	CcSEcCtD
Dorzolamide—Oedema—Dactinomycin—uterine cancer	0.000928	0.00197	CcSEcCtD
Dorzolamide—Blood urea increased—Doxorubicin—uterine cancer	0.000922	0.00195	CcSEcCtD
Dorzolamide—Dry eye—Doxorubicin—uterine cancer	0.000902	0.00191	CcSEcCtD
Dorzolamide—Diarrhoea—Progesterone—uterine cancer	0.000899	0.0019	CcSEcCtD
Dorzolamide—Erythema multiforme—Etoposide—uterine cancer	0.000894	0.00189	CcSEcCtD
Dorzolamide—Anorexia—Dactinomycin—uterine cancer	0.000885	0.00187	CcSEcCtD
Dorzolamide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000877	0.00186	CcSEcCtD
Dorzolamide—Pulmonary oedema—Doxorubicin—uterine cancer	0.000869	0.00184	CcSEcCtD
Dorzolamide—Dizziness—Progesterone—uterine cancer	0.000869	0.00184	CcSEcCtD
Dorzolamide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000854	0.00181	CcSEcCtD
Dorzolamide—Eye pain—Epirubicin—uterine cancer	0.000849	0.0018	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000846	0.00179	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Epirubicin—uterine cancer	0.000845	0.00179	CcSEcCtD
Dorzolamide—CA2—lymph node—uterine cancer	0.000843	0.0107	CbGeAlD
Dorzolamide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000842	0.00178	CcSEcCtD
Dorzolamide—Alopecia—Etoposide—uterine cancer	0.000836	0.00177	CcSEcCtD
Dorzolamide—Vomiting—Progesterone—uterine cancer	0.000835	0.00177	CcSEcCtD
Dorzolamide—Rash—Progesterone—uterine cancer	0.000828	0.00175	CcSEcCtD
Dorzolamide—Dermatitis—Progesterone—uterine cancer	0.000827	0.00175	CcSEcCtD
Dorzolamide—Headache—Progesterone—uterine cancer	0.000823	0.00174	CcSEcCtD
Dorzolamide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000814	0.00172	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000812	0.00172	CcSEcCtD
Dorzolamide—Decreased appetite—Dactinomycin—uterine cancer	0.000807	0.00171	CcSEcCtD
Dorzolamide—Dysgeusia—Etoposide—uterine cancer	0.000806	0.00171	CcSEcCtD
Dorzolamide—Fatigue—Dactinomycin—uterine cancer	0.0008	0.00169	CcSEcCtD
Dorzolamide—Back pain—Etoposide—uterine cancer	0.000796	0.00169	CcSEcCtD
Dorzolamide—Pain—Dactinomycin—uterine cancer	0.000794	0.00168	CcSEcCtD
Dorzolamide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000787	0.00167	CcSEcCtD
Dorzolamide—Eye pain—Doxorubicin—uterine cancer	0.000785	0.00166	CcSEcCtD
Dorzolamide—Cardiac failure—Epirubicin—uterine cancer	0.000785	0.00166	CcSEcCtD
Dorzolamide—Hypoglycaemia—Epirubicin—uterine cancer	0.000785	0.00166	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Epirubicin—uterine cancer	0.000782	0.00166	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000782	0.00166	CcSEcCtD
Dorzolamide—Nausea—Progesterone—uterine cancer	0.00078	0.00165	CcSEcCtD
Dorzolamide—Diplopia—Epirubicin—uterine cancer	0.000766	0.00162	CcSEcCtD
Dorzolamide—Pain in extremity—Epirubicin—uterine cancer	0.000766	0.00162	CcSEcCtD
Dorzolamide—Feeling abnormal—Dactinomycin—uterine cancer	0.000765	0.00162	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000759	0.00161	CcSEcCtD
Dorzolamide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000757	0.0016	CcSEcCtD
Dorzolamide—Affect lability—Epirubicin—uterine cancer	0.000754	0.0016	CcSEcCtD
Dorzolamide—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000751	0.00159	CcSEcCtD
Dorzolamide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00075	0.00159	CcSEcCtD
Dorzolamide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00075	0.00159	CcSEcCtD
Dorzolamide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000746	0.00158	CcSEcCtD
Dorzolamide—Vertigo—Etoposide—uterine cancer	0.00074	0.00157	CcSEcCtD
Dorzolamide—Body temperature increased—Dactinomycin—uterine cancer	0.000734	0.00155	CcSEcCtD
Dorzolamide—Abdominal pain—Dactinomycin—uterine cancer	0.000734	0.00155	CcSEcCtD
Dorzolamide—Cardiac arrest—Epirubicin—uterine cancer	0.000729	0.00154	CcSEcCtD
Dorzolamide—Cardiac failure—Doxorubicin—uterine cancer	0.000727	0.00154	CcSEcCtD
Dorzolamide—Hypoglycaemia—Doxorubicin—uterine cancer	0.000727	0.00154	CcSEcCtD
Dorzolamide—Mood swings—Epirubicin—uterine cancer	0.000726	0.00154	CcSEcCtD
Dorzolamide—Loss of consciousness—Etoposide—uterine cancer	0.000724	0.00153	CcSEcCtD
Dorzolamide—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000724	0.00153	CcSEcCtD
Dorzolamide—Cough—Etoposide—uterine cancer	0.000718	0.00152	CcSEcCtD
Dorzolamide—Hypertension—Etoposide—uterine cancer	0.000711	0.00151	CcSEcCtD
Dorzolamide—Diplopia—Doxorubicin—uterine cancer	0.000709	0.0015	CcSEcCtD
Dorzolamide—Pain in extremity—Doxorubicin—uterine cancer	0.000709	0.0015	CcSEcCtD
Dorzolamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000707	0.0015	CcSEcCtD
Dorzolamide—Chest pain—Etoposide—uterine cancer	0.000701	0.00148	CcSEcCtD
Dorzolamide—Affect lability—Doxorubicin—uterine cancer	0.000698	0.00148	CcSEcCtD
Dorzolamide—Discomfort—Etoposide—uterine cancer	0.000693	0.00147	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00069	0.00146	CcSEcCtD
Dorzolamide—Hypersensitivity—Dactinomycin—uterine cancer	0.000684	0.00145	CcSEcCtD
Dorzolamide—Confusional state—Etoposide—uterine cancer	0.000678	0.00143	CcSEcCtD
Dorzolamide—Cardiac arrest—Doxorubicin—uterine cancer	0.000674	0.00143	CcSEcCtD
Dorzolamide—Anaphylactic shock—Etoposide—uterine cancer	0.000672	0.00142	CcSEcCtD
Dorzolamide—Mood swings—Doxorubicin—uterine cancer	0.000672	0.00142	CcSEcCtD
Dorzolamide—Asthenia—Dactinomycin—uterine cancer	0.000666	0.00141	CcSEcCtD
Dorzolamide—Influenza—Epirubicin—uterine cancer	0.000662	0.0014	CcSEcCtD
Dorzolamide—Hyperhidrosis—Etoposide—uterine cancer	0.00065	0.00138	CcSEcCtD
Dorzolamide—Angina pectoris—Epirubicin—uterine cancer	0.000645	0.00137	CcSEcCtD
Dorzolamide—Anorexia—Etoposide—uterine cancer	0.000641	0.00136	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000639	0.00135	CcSEcCtD
Dorzolamide—Bronchitis—Epirubicin—uterine cancer	0.000637	0.00135	CcSEcCtD
Dorzolamide—Diarrhoea—Dactinomycin—uterine cancer	0.000635	0.00135	CcSEcCtD
Dorzolamide—Hypotension—Etoposide—uterine cancer	0.000628	0.00133	CcSEcCtD
Dorzolamide—Dysuria—Epirubicin—uterine cancer	0.000619	0.00131	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000616	0.0013	CcSEcCtD
Dorzolamide—Influenza—Doxorubicin—uterine cancer	0.000613	0.0013	CcSEcCtD
Dorzolamide—Paraesthesia—Etoposide—uterine cancer	0.000603	0.00128	CcSEcCtD
Dorzolamide—Weight decreased—Epirubicin—uterine cancer	0.000599	0.00127	CcSEcCtD
Dorzolamide—Dyspnoea—Etoposide—uterine cancer	0.000599	0.00127	CcSEcCtD
Dorzolamide—Hyperglycaemia—Epirubicin—uterine cancer	0.000597	0.00127	CcSEcCtD
Dorzolamide—Somnolence—Etoposide—uterine cancer	0.000597	0.00126	CcSEcCtD
Dorzolamide—Angina pectoris—Doxorubicin—uterine cancer	0.000597	0.00126	CcSEcCtD
Dorzolamide—Vomiting—Dactinomycin—uterine cancer	0.00059	0.00125	CcSEcCtD
Dorzolamide—Bronchitis—Doxorubicin—uterine cancer	0.000589	0.00125	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000586	0.00124	CcSEcCtD
Dorzolamide—Rash—Dactinomycin—uterine cancer	0.000585	0.00124	CcSEcCtD
Dorzolamide—Decreased appetite—Etoposide—uterine cancer	0.000584	0.00124	CcSEcCtD
Dorzolamide—Fatigue—Etoposide—uterine cancer	0.000579	0.00123	CcSEcCtD
Dorzolamide—Pain—Etoposide—uterine cancer	0.000575	0.00122	CcSEcCtD
Dorzolamide—Urinary tract infection—Epirubicin—uterine cancer	0.000574	0.00122	CcSEcCtD
Dorzolamide—Conjunctivitis—Epirubicin—uterine cancer	0.000574	0.00122	CcSEcCtD
Dorzolamide—Dysuria—Doxorubicin—uterine cancer	0.000573	0.00121	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.00057	0.00121	CcSEcCtD
Dorzolamide—Sweating—Epirubicin—uterine cancer	0.000566	0.0012	CcSEcCtD
Dorzolamide—Epistaxis—Epirubicin—uterine cancer	0.000557	0.00118	CcSEcCtD
Dorzolamide—Weight decreased—Doxorubicin—uterine cancer	0.000554	0.00117	CcSEcCtD
Dorzolamide—Sinusitis—Epirubicin—uterine cancer	0.000554	0.00117	CcSEcCtD
Dorzolamide—Feeling abnormal—Etoposide—uterine cancer	0.000554	0.00117	CcSEcCtD
Dorzolamide—Hyperglycaemia—Doxorubicin—uterine cancer	0.000553	0.00117	CcSEcCtD
Dorzolamide—Nausea—Dactinomycin—uterine cancer	0.000551	0.00117	CcSEcCtD
Dorzolamide—Agranulocytosis—Epirubicin—uterine cancer	0.000551	0.00117	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Etoposide—uterine cancer	0.000549	0.00116	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000542	0.00115	CcSEcCtD
Dorzolamide—Bradycardia—Epirubicin—uterine cancer	0.00054	0.00114	CcSEcCtD
Dorzolamide—Urticaria—Etoposide—uterine cancer	0.000534	0.00113	CcSEcCtD
Dorzolamide—Abdominal pain—Etoposide—uterine cancer	0.000531	0.00112	CcSEcCtD
Dorzolamide—Body temperature increased—Etoposide—uterine cancer	0.000531	0.00112	CcSEcCtD
Dorzolamide—Urinary tract infection—Doxorubicin—uterine cancer	0.000531	0.00112	CcSEcCtD
Dorzolamide—Conjunctivitis—Doxorubicin—uterine cancer	0.000531	0.00112	CcSEcCtD
Dorzolamide—Pharyngitis—Epirubicin—uterine cancer	0.000526	0.00111	CcSEcCtD
Dorzolamide—Sweating—Doxorubicin—uterine cancer	0.000524	0.00111	CcSEcCtD
Dorzolamide—Epistaxis—Doxorubicin—uterine cancer	0.000515	0.00109	CcSEcCtD
Dorzolamide—Sinusitis—Doxorubicin—uterine cancer	0.000513	0.00109	CcSEcCtD
Dorzolamide—Visual impairment—Epirubicin—uterine cancer	0.000511	0.00108	CcSEcCtD
Dorzolamide—Agranulocytosis—Doxorubicin—uterine cancer	0.00051	0.00108	CcSEcCtD
Dorzolamide—Erythema multiforme—Epirubicin—uterine cancer	0.000501	0.00106	CcSEcCtD
Dorzolamide—Bradycardia—Doxorubicin—uterine cancer	0.000499	0.00106	CcSEcCtD
Dorzolamide—Hypersensitivity—Etoposide—uterine cancer	0.000495	0.00105	CcSEcCtD
Dorzolamide—Tinnitus—Epirubicin—uterine cancer	0.000494	0.00105	CcSEcCtD
Dorzolamide—Pharyngitis—Doxorubicin—uterine cancer	0.000487	0.00103	CcSEcCtD
Dorzolamide—Asthenia—Etoposide—uterine cancer	0.000482	0.00102	CcSEcCtD
Dorzolamide—Pruritus—Etoposide—uterine cancer	0.000475	0.00101	CcSEcCtD
Dorzolamide—Arrhythmia—Epirubicin—uterine cancer	0.000474	0.001	CcSEcCtD
Dorzolamide—Visual impairment—Doxorubicin—uterine cancer	0.000473	0.001	CcSEcCtD
Dorzolamide—Alopecia—Epirubicin—uterine cancer	0.000468	0.000992	CcSEcCtD
Dorzolamide—Erythema multiforme—Doxorubicin—uterine cancer	0.000464	0.000982	CcSEcCtD
Dorzolamide—Erythema—Epirubicin—uterine cancer	0.000462	0.000977	CcSEcCtD
Dorzolamide—Diarrhoea—Etoposide—uterine cancer	0.00046	0.000973	CcSEcCtD
Dorzolamide—Tinnitus—Doxorubicin—uterine cancer	0.000457	0.000968	CcSEcCtD
Dorzolamide—Tension—Epirubicin—uterine cancer	0.000453	0.000959	CcSEcCtD
Dorzolamide—Dysgeusia—Epirubicin—uterine cancer	0.000452	0.000957	CcSEcCtD
Dorzolamide—Nervousness—Epirubicin—uterine cancer	0.000448	0.000949	CcSEcCtD
Dorzolamide—Back pain—Epirubicin—uterine cancer	0.000446	0.000945	CcSEcCtD
Dorzolamide—Dizziness—Etoposide—uterine cancer	0.000444	0.000941	CcSEcCtD
Dorzolamide—Arrhythmia—Doxorubicin—uterine cancer	0.000438	0.000928	CcSEcCtD
Dorzolamide—Vision blurred—Epirubicin—uterine cancer	0.000435	0.000921	CcSEcCtD
Dorzolamide—Alopecia—Doxorubicin—uterine cancer	0.000433	0.000918	CcSEcCtD
Dorzolamide—Vomiting—Etoposide—uterine cancer	0.000427	0.000905	CcSEcCtD
Dorzolamide—Erythema—Doxorubicin—uterine cancer	0.000427	0.000904	CcSEcCtD
Dorzolamide—Rash—Etoposide—uterine cancer	0.000424	0.000897	CcSEcCtD
Dorzolamide—Dermatitis—Etoposide—uterine cancer	0.000423	0.000896	CcSEcCtD
Dorzolamide—Headache—Etoposide—uterine cancer	0.000421	0.000891	CcSEcCtD
Dorzolamide—Tension—Doxorubicin—uterine cancer	0.000419	0.000887	CcSEcCtD
Dorzolamide—Dysgeusia—Doxorubicin—uterine cancer	0.000418	0.000885	CcSEcCtD
Dorzolamide—Nervousness—Doxorubicin—uterine cancer	0.000415	0.000878	CcSEcCtD
Dorzolamide—Vertigo—Epirubicin—uterine cancer	0.000415	0.000878	CcSEcCtD
Dorzolamide—Syncope—Epirubicin—uterine cancer	0.000414	0.000876	CcSEcCtD
Dorzolamide—Back pain—Doxorubicin—uterine cancer	0.000413	0.000875	CcSEcCtD
Dorzolamide—Palpitations—Epirubicin—uterine cancer	0.000408	0.000864	CcSEcCtD
Dorzolamide—Loss of consciousness—Epirubicin—uterine cancer	0.000406	0.000859	CcSEcCtD
Dorzolamide—Cough—Epirubicin—uterine cancer	0.000403	0.000853	CcSEcCtD
Dorzolamide—Vision blurred—Doxorubicin—uterine cancer	0.000402	0.000852	CcSEcCtD
Dorzolamide—Nausea—Etoposide—uterine cancer	0.000399	0.000845	CcSEcCtD
Dorzolamide—Hypertension—Epirubicin—uterine cancer	0.000398	0.000844	CcSEcCtD
Dorzolamide—Arthralgia—Epirubicin—uterine cancer	0.000393	0.000832	CcSEcCtD
Dorzolamide—Chest pain—Epirubicin—uterine cancer	0.000393	0.000832	CcSEcCtD
Dorzolamide—Anxiety—Epirubicin—uterine cancer	0.000392	0.000829	CcSEcCtD
Dorzolamide—Discomfort—Epirubicin—uterine cancer	0.000388	0.000822	CcSEcCtD
Dorzolamide—Dry mouth—Epirubicin—uterine cancer	0.000384	0.000814	CcSEcCtD
Dorzolamide—Vertigo—Doxorubicin—uterine cancer	0.000384	0.000812	CcSEcCtD
Dorzolamide—Syncope—Doxorubicin—uterine cancer	0.000383	0.000811	CcSEcCtD
Dorzolamide—Confusional state—Epirubicin—uterine cancer	0.00038	0.000804	CcSEcCtD
Dorzolamide—Palpitations—Doxorubicin—uterine cancer	0.000377	0.000799	CcSEcCtD
Dorzolamide—Oedema—Epirubicin—uterine cancer	0.000377	0.000798	CcSEcCtD
Dorzolamide—Anaphylactic shock—Epirubicin—uterine cancer	0.000377	0.000798	CcSEcCtD
Dorzolamide—Loss of consciousness—Doxorubicin—uterine cancer	0.000375	0.000795	CcSEcCtD
Dorzolamide—Cough—Doxorubicin—uterine cancer	0.000373	0.000789	CcSEcCtD
Dorzolamide—Shock—Epirubicin—uterine cancer	0.000371	0.000785	CcSEcCtD
Dorzolamide—Hypertension—Doxorubicin—uterine cancer	0.000369	0.000781	CcSEcCtD
Dorzolamide—Hyperhidrosis—Epirubicin—uterine cancer	0.000364	0.000771	CcSEcCtD
Dorzolamide—Chest pain—Doxorubicin—uterine cancer	0.000364	0.00077	CcSEcCtD
Dorzolamide—Arthralgia—Doxorubicin—uterine cancer	0.000364	0.00077	CcSEcCtD
Dorzolamide—Anxiety—Doxorubicin—uterine cancer	0.000362	0.000767	CcSEcCtD
Dorzolamide—Discomfort—Doxorubicin—uterine cancer	0.000359	0.000761	CcSEcCtD
Dorzolamide—Anorexia—Epirubicin—uterine cancer	0.000359	0.00076	CcSEcCtD
Dorzolamide—Dry mouth—Doxorubicin—uterine cancer	0.000356	0.000753	CcSEcCtD
Dorzolamide—Hypotension—Epirubicin—uterine cancer	0.000352	0.000745	CcSEcCtD
Dorzolamide—Confusional state—Doxorubicin—uterine cancer	0.000351	0.000744	CcSEcCtD
Dorzolamide—Anaphylactic shock—Doxorubicin—uterine cancer	0.000349	0.000738	CcSEcCtD
Dorzolamide—Oedema—Doxorubicin—uterine cancer	0.000349	0.000738	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000343	0.000727	CcSEcCtD
Dorzolamide—Shock—Doxorubicin—uterine cancer	0.000343	0.000726	CcSEcCtD
Dorzolamide—Insomnia—Epirubicin—uterine cancer	0.000341	0.000721	CcSEcCtD
Dorzolamide—Paraesthesia—Epirubicin—uterine cancer	0.000338	0.000716	CcSEcCtD
Dorzolamide—Hyperhidrosis—Doxorubicin—uterine cancer	0.000337	0.000713	CcSEcCtD
Dorzolamide—Dyspnoea—Epirubicin—uterine cancer	0.000336	0.000711	CcSEcCtD
Dorzolamide—Somnolence—Epirubicin—uterine cancer	0.000335	0.000709	CcSEcCtD
Dorzolamide—Anorexia—Doxorubicin—uterine cancer	0.000332	0.000703	CcSEcCtD
Dorzolamide—Dyspepsia—Epirubicin—uterine cancer	0.000332	0.000702	CcSEcCtD
Dorzolamide—Decreased appetite—Epirubicin—uterine cancer	0.000327	0.000693	CcSEcCtD
Dorzolamide—Hypotension—Doxorubicin—uterine cancer	0.000326	0.00069	CcSEcCtD
Dorzolamide—Fatigue—Epirubicin—uterine cancer	0.000325	0.000688	CcSEcCtD
Dorzolamide—Pain—Epirubicin—uterine cancer	0.000322	0.000682	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000318	0.000672	CcSEcCtD
Dorzolamide—Insomnia—Doxorubicin—uterine cancer	0.000315	0.000667	CcSEcCtD
Dorzolamide—Paraesthesia—Doxorubicin—uterine cancer	0.000313	0.000663	CcSEcCtD
Dorzolamide—Dyspnoea—Doxorubicin—uterine cancer	0.000311	0.000658	CcSEcCtD
Dorzolamide—Feeling abnormal—Epirubicin—uterine cancer	0.00031	0.000657	CcSEcCtD
Dorzolamide—Somnolence—Doxorubicin—uterine cancer	0.00031	0.000656	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000308	0.000652	CcSEcCtD
Dorzolamide—Dyspepsia—Doxorubicin—uterine cancer	0.000307	0.00065	CcSEcCtD
Dorzolamide—Decreased appetite—Doxorubicin—uterine cancer	0.000303	0.000641	CcSEcCtD
Dorzolamide—Fatigue—Doxorubicin—uterine cancer	0.0003	0.000636	CcSEcCtD
Dorzolamide—Urticaria—Epirubicin—uterine cancer	0.000299	0.000634	CcSEcCtD
Dorzolamide—Pain—Doxorubicin—uterine cancer	0.000298	0.000631	CcSEcCtD
Dorzolamide—Abdominal pain—Epirubicin—uterine cancer	0.000298	0.00063	CcSEcCtD
Dorzolamide—Body temperature increased—Epirubicin—uterine cancer	0.000298	0.00063	CcSEcCtD
Dorzolamide—Feeling abnormal—Doxorubicin—uterine cancer	0.000287	0.000608	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000285	0.000603	CcSEcCtD
Dorzolamide—Hypersensitivity—Epirubicin—uterine cancer	0.000278	0.000588	CcSEcCtD
Dorzolamide—Urticaria—Doxorubicin—uterine cancer	0.000277	0.000586	CcSEcCtD
Dorzolamide—Abdominal pain—Doxorubicin—uterine cancer	0.000276	0.000583	CcSEcCtD
Dorzolamide—Body temperature increased—Doxorubicin—uterine cancer	0.000276	0.000583	CcSEcCtD
Dorzolamide—Asthenia—Epirubicin—uterine cancer	0.00027	0.000572	CcSEcCtD
Dorzolamide—Pruritus—Epirubicin—uterine cancer	0.000266	0.000564	CcSEcCtD
Dorzolamide—Diarrhoea—Epirubicin—uterine cancer	0.000258	0.000546	CcSEcCtD
Dorzolamide—Hypersensitivity—Doxorubicin—uterine cancer	0.000257	0.000544	CcSEcCtD
Dorzolamide—Asthenia—Doxorubicin—uterine cancer	0.00025	0.000529	CcSEcCtD
Dorzolamide—Dizziness—Epirubicin—uterine cancer	0.000249	0.000527	CcSEcCtD
Dorzolamide—Pruritus—Doxorubicin—uterine cancer	0.000247	0.000522	CcSEcCtD
Dorzolamide—Vomiting—Epirubicin—uterine cancer	0.000239	0.000507	CcSEcCtD
Dorzolamide—Diarrhoea—Doxorubicin—uterine cancer	0.000238	0.000505	CcSEcCtD
Dorzolamide—Rash—Epirubicin—uterine cancer	0.000237	0.000503	CcSEcCtD
Dorzolamide—Dermatitis—Epirubicin—uterine cancer	0.000237	0.000502	CcSEcCtD
Dorzolamide—Headache—Epirubicin—uterine cancer	0.000236	0.0005	CcSEcCtD
Dorzolamide—Dizziness—Doxorubicin—uterine cancer	0.00023	0.000488	CcSEcCtD
Dorzolamide—Nausea—Epirubicin—uterine cancer	0.000224	0.000474	CcSEcCtD
Dorzolamide—Vomiting—Doxorubicin—uterine cancer	0.000222	0.000469	CcSEcCtD
Dorzolamide—Rash—Doxorubicin—uterine cancer	0.00022	0.000465	CcSEcCtD
Dorzolamide—Dermatitis—Doxorubicin—uterine cancer	0.00022	0.000465	CcSEcCtD
Dorzolamide—Headache—Doxorubicin—uterine cancer	0.000218	0.000462	CcSEcCtD
Dorzolamide—Nausea—Doxorubicin—uterine cancer	0.000207	0.000438	CcSEcCtD
